Your browser doesn't support javascript.
loading
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
Gisondi, Paolo; Gottlieb, Alice B; Elewski, Boni; Augustin, Matthias; McBride, Sandy; Tsai, Tsen-Fang; de la Loge, Christine; Fierens, Frederik; López Pinto, José M; Tilt, Nicola; Lebwohl, Mark.
Affiliation
  • Gisondi P; Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
  • Gottlieb AB; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Elewski B; Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA.
  • Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • McBride S; Royal Free London NHS Foundation Trust, London, UK.
  • Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • de la Loge C; PCOM Analytics, Avallon, France.
  • Fierens F; UCB Pharma, Brussels, Belgium.
  • López Pinto JM; UCB Pharma, Madrid, Spain.
  • Tilt N; UCB Pharma, Slough, UK.
  • Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. lebwohl@aol.com.
Dermatol Ther (Heidelb) ; 13(1): 315-328, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36509889

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2023 Document type: Article